Page last updated: 2024-09-04

sinensetin and epicatechin

sinensetin has been researched along with epicatechin in 2 studies

Compound Research Comparison

Studies
(sinensetin)
Trials
(sinensetin)
Recent Studies (post-2010)
(sinensetin)
Studies
(epicatechin)
Trials
(epicatechin)
Recent Studies (post-2010) (epicatechin)
56042111051

Protein Interaction Comparison

ProteinTaxonomysinensetin (IC50)epicatechin (IC50)
M18 aspartyl aminopeptidasePlasmodium falciparum 3D71.376
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproproteinHomo sapiens (human)0.407
intestinal alkaline phosphatase precursorMus musculus (house mouse)1.36
rac GTPase-activating protein 1 isoform aHomo sapiens (human)205.62
Arginase Leishmania amazonensis1.6
Pyruvate kinase PKMHomo sapiens (human)1.33
Alpha-synucleinHomo sapiens (human)0.8
DNA repair protein RAD52 homologHomo sapiens (human)1.45

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

2 other study(ies) available for sinensetin and epicatechin

ArticleYear
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
    Journal of natural products, 1999, Volume: 62, Issue:3

    Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

1999
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012